Especially for biotechnology and pharmaceutical companies, the Madrid Protocol for international trademark registration marks a new era in trademark protection.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Landes, W.M. & Posner, R.A. 78 Trademark Rep. 267 (1986).
Kuhlman, G.A. 11 Berkley Tech. L. J. 311 (1996).
Ginsburg, J.C., Litman, J. & Kevlin, M.L. Trademark and Unfair Competition Law (Foundation Press, New York, 2001).
See http://www.uspto.gov for USPTO serial number 76273640.
Hamilton, G.W. 4 Tex. Intell. Prop. L. J. 1 (1995).
Perry, E.L. & McHugh, M.C. Nat. Biotechnol. 20, 627–628 (2002).
For a description of domestic registration, see http://www.uspto.gov/main/trademarks.htm.
15 USC § 1051.
See http://www.gene.com.
USPTO serial number 73416672.
USPTO serial number 76425595.
USPTO serial number 76252353.
Public Law 107-273 at §13403; 116 Stat. 1921.
Madrid Agreement Concerning the International Registration of Marks, 1989, Article 4(2).
Id. at Article 7.
Supra reference 15 at Article 6(2).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Simmons, W. Effecting a comprehensive intellectual property strategy using the Madrid Protocol. Nat Biotechnol 22, 603–605 (2004). https://doi.org/10.1038/nbt0504-603
Issue Date:
DOI: https://doi.org/10.1038/nbt0504-603